Jae‐Sook Ahn

The 2016 revision of the World Health Organization classification of lymphoid neoplasms

Role of Imaging in the Staging and Response Assessment of Lymphoma: Consensus of the International Conference on Malignant Lymphomas Imaging Working Group

T-cell tolerance and exhaustion in the clearance of Echinococcus multilocularis: role of inoculum size in a quantitative hepatic experimental model

Guillain-Barré syndrome

Osteosarcoma treatment – Where do we stand? A state of the art review

TET enzymes, TDG and the dynamics of DNA demethylation

Osteosarcoma: improvement in survival limited to high-grade patients only

Therapy with azanucleosides for myelodysplastic syndromes

NK cell-based immunotherapy for malignant diseases

ROBOTS AS SOCIAL ACTORS: AURORA AND THE CASE OF AUTISM

Innate Immunity to Campylobacter jejuni in Guillain‐Barré Syndrome

EBV-positive large B-cell lymphomas in young patients: a nodal lymphoma with evidence for a tolerogenic immune environment

Echinococcosis: Advances in the 21st Century

PD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy: Mechanisms, response biomarkers, and combinations

Recommendations for Initial Evaluation, Staging, and Response Assessment of Hodgkin and Non-Hodgkin Lymphoma: The Lugano Classification

Socially intelligent robots: dimensions of human–robot interaction

Strategies for Combining Immunotherapy with Radiation for Anticancer Therapy

Endothelial activation and stress index (EASIX) is a reliable predictor for overall survival in patients with multiple myeloma

Interim PET/CT-based prognostic model for the treatment of diffuse large B cell lymphoma in the post-rituximab era

Type I and II interferons enhance dendritic cell maturation and migration capacity by regulating CD38 and CD74 that have synergistic effects with TLR agonists

Prognostic significance of interim 18F-FDG PET/CT after three or four cycles of R-CHOP chemotherapy in the treatment of diffuse large B-cell lymphoma

Naïve CD8+ T cell derived tumor-specific cytotoxic effectors as a potential remedy for overcoming TGF-β immunosuppression in the tumor microenvironment

Clinical outcome of elderly patients with Epstein–Barr virus positive diffuse large B‐cell lymphoma treated with a combination of rituximab and CHOP chemotherapy

Newly Developed Multiple Myeloma in a Patient with Primary T-Cell Lymphoma of Bone

Optimal culture conditions for the generation of natural killer cell-induced dendritic cells for cancer immunotherapy

Genome-Wide DNA Methylation Analysis of Patients with Myelodysplastic Syndrome After Azacitidine Treatment.